Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Sales (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Return on Sales for 4 consecutive years, with 1.97% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 63.0% to 1.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.42% through Dec 2025, down 145.0% year-over-year, with the annual reading at 2.42% for FY2025, 145.0% down from the prior year.
  • Return on Sales for Q4 2025 was 1.97% at bioAffinity Technologies, up from 3.49% in the prior quarter.
  • The five-year high for Return on Sales was 0.82% in Q1 2024, with the low at 4277.79% in Q3 2022.
  • Average Return on Sales over 4 years is 455.61%, with a median of 3.2% recorded in 2025.
  • Peak annual rise in Return on Sales hit 427011bps in 2023, while the deepest fall reached -2074bps in 2023.
  • Over 4 years, Return on Sales stood at 713.8% in 2022, then skyrocketed by 100bps to 1.07% in 2023, then fell by -25bps to 1.34% in 2024, then crashed by -47bps to 1.97% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.97%, 3.49%, and 3.2% for Q4 2025, Q3 2025, and Q2 2025 respectively.